(Q46570046)

23 December 2017

title

An automated biological assay to determine levels of the trypanocidal drug melarsoprol in biological fluids (English)

1 reference

23 December 2017

0 references

Onyango JD

1

1 reference

23 December 2017

Burri C

series ordinal

2

1 reference

23 December 2017

Brun R

series ordinal

3

1 reference

23 December 2017

publication date

1 January 2000

1 reference

23 December 2017

published in

Acta Tropica

1 reference

23 December 2017

volume

74

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

95-100

1 reference

23 December 2017

High-performance liquid chromatographic method for the separation and quantitative estimation of anti-parasitic melaminophenyl arsenical compounds

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

Trypanosoma (Nannomonas) congolense: Changes in respiratory metabolism during the life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

Discrepancy in plasma melarsoprol concentrations between HPLC and bioassay methods in patients with T. gambiense sleeping sickness indicates that melarsoprol is metabolized

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

In vitro drug sensitivity test for Trypanosoma brucei subgroup bloodstream trypomastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

Pharmacokinetics of melarsoprol in uninfected vervet monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

Pharmacokinetic properties of the trypanocidal drug melarsoprol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

Determination of melarsoprol in biological fluids by high-performance liquid chromatography and characterisation of two stereoisomers by nuclear magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

Mel B in the treatment of human trypanosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

Trypanosoma brucei brucei: expression of drug resistance in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

Current situation of African trypanosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

Treatment of Rhodesian sleeping sickness in Kenya.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900080-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-706X(99)00080-7

1 reference

23 December 2017

1 reference

23 December 2017